Clinical Trial Update: Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for FURESTEM-CD in moderately active Crohn's disease (Phase 1/Phase 2) with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• FURESTEM-CD Inj. (FURESTEM-CD)

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Crohn's Disease | Phase 1, Phase 2 | Status: UNKNOWN